Biomarkers have moved from a research tool to a core part of how modern medicine is practiced. They help clinicians detect disease earlier, match patients to the right therapy, and help drug developers decide which candidates deserve further investment. According to Grand View Research, the global biomarkers market was valued at USD 81.0 billion in 2023. It is estimated at USD 117.1 billion in...